© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 8, 570-571,
April 16, 2003
© 2003 Oxford University Press
EDITORIAL |
Standard Consultations Are Not Enough to Ensure Decision Quality Regarding Preference-Sensitive Options
Affiliations of authors: A. M. O’Connor, University of Ottawa and Ottawa Health Research Institute, Canada; A. G. Mulley, Jr., Massachusetts General Hospital and Harvard Medical School, Boston, MA; J. E. Wennberg, Clinical Evaluative Sciences, Dartmouth Medical School, Hanover, NH.
Correspondence to: John E. Wennberg, M.D., M.P.H., Center for the Evaluative Clinical Sciences, Dartmouth Medical School, Hanover, NH 03755 (e-mail: john.wennberg@dartmouth.edu).
| The first 10% of the full text of this article appears below. |
Widespread variation in medical practices and outcomes in seemingly similar populations has raised serious concerns about the quality of health care (1). Well-documented variations in outcomes can be explained partly by failures to apply best practices consistently in delivering care known to be effective (1,2). Equally important, however, are variations in rates of specific surgical or medical interventions in seemingly similar populations that reflect inadequate appreciation for the importance of individual patients’ well-informed preferences for care and subsequent health outcomes (3,4). Efforts to improve patient-centered decision quality are especially critical to ensuring quality cancer care (5).
Making a good decision about cancer treatment is a complex and difficult
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. D. Throckmorton and L. J. Esserman When Informed, All Women Do Not Prefer Breast Conservation J. Clin. Oncol., February 1, 2009; 27(4): 484 - 486. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Barry, D. S. Kaufman, and C.-L. Wu Case 15-2008 -- A 55-Year-Old Man with an Elevated Prostate-Specific Antigen Level and Early-Stage Prostate Cancer N. Engl. J. Med., May 15, 2008; 358(20): 2161 - 2168. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Barnato, H. A. Llewellyn-Thomas, E. M. Peters, L. Siminoff, E. D. Collins, and M. J. Barry Communication and Decision Making in Cancer Care: Setting Research Priorities for Decision Support/Patients' Decision Aids Med Decis Making, October 1, 2007; 27(5): 626 - 634. [Abstract] [PDF]
|
|
|
|
 |
|
 D. C. Miller, S. B. Gruber, B. K. Hollenbeck, J. E. Montie, and J. T. Wei Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst, August 16, 2006; 98(16): 1134 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Ropka, J. Wenzel, E. K. Phillips, M. Siadaty, and J. T. Philbrick Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 840 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Col, G. Weber, A. Stiggelbout, J. Chuo, R. D'Agostino, and P. Corso Short-term Menopausal Hormone Therapy for Symptom Relief: An Updated Decision Model Arch Intern Med, August 9, 2004; 164(15): 1634 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Whelan, M. Levine, A. Willan, A. Gafni, K. Sanders, D. Mirsky, S. Chambers, M. A. O'Brien, S. Reid, and S. Dubois Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery: A Randomized Trial JAMA, July 28, 2004; 292(4): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goodwin Reversible Ovarian Ablation or Chemotherapy: Are We Ready for Quality of Life to Guide Adjuvant Treatment Decisions in Breast Cancer? J. Clin. Oncol., December 15, 2003; 21(24): 4474 - 4475. [Full Text] [PDF]
|
|